This study presents a hypothesis on the potential benefits of early, low-dose hormone replacement therapy (HRT) in healthy perimenopausal women, particularly in improving metabolic syndrome components and reducing cardiovascular risk. However, the article does not provide empirical data to support these claims and is based purely on theoretical assumptions. It
